Search results
Will GSK Stock Rebound To Its 2022 Highs Of $47?
Forbes· 3 days agoGSK plc stock (NYSE: GSK) trades at $38 per share, about 20% below its peak level of over $47 seen in April 2022.
GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
Zacks via Yahoo Finance UK· 3 days agoGSK revamps its existing collaboration deal with partner CureVac, converting it from a collaboration...
Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
Zacks via Yahoo Finance UK· 4 days agoIt was a regular week for the biotech sector with quite a few important pipeline and regulatory...
Should We Be Delighted With GSK plc's (LON:GSK) ROE Of 36%?
Simply Wall St. via Yahoo Finance UK· 4 days agoWhile some investors are already well versed in financial metrics (hat tip), this article is for...
CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine
Zacks via Yahoo Finance UK· 6 days agoModerna’s stock also took a hit last week after it presented new data on mResvia to the CDC, which...